Notice2025-00454
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 13, 2025
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 7 (Monday, January 13, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 7 (Monday, January 13, 2025)]
[Notices]
[Pages 2704-2706]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-00454]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-25-1385]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Characteristics of Cases of Priority Fungal
Diseases'' to the Office of Management and Budget (OMB) for review and
approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on October
25, 2024, to obtain comments from the public and affected agencies. CDC
did not receive comments related to the previous notice. This notice
serves to allow an additional 30 days for public and affected agency
comments.
[[Page 2705]]
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Characteristics of Cases of Priority Fungal Diseases (OMB Control
No. 0920-1385, Exp. 4/30/2027)--Revision--National Center for Emerging
and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Fungal diseases cause substantial illness, ranging from mild
infection to severe or life-threatening invasive disease. They also
constitute a considerable financial burden on patients and healthcare
systems. Awareness of fungal diseases is low, and data collection has
historically been limited in size, scope, and coordination, which has
hindered our understanding of these diseases. Detailed epidemiologic
and clinical data are critical to inform appropriate public health
responses. We plan to enhance surveillance of high priority fungal
diseases across the United States to better characterize factors such
as disease burden, geographic scope, patient risk factors, health
disparities, healthcare utilization, outcomes, and emerging trends.
This project will serve as a Revision of the information collections
project: Characteristics of Cases of Priority Fungal Diseases Case
Report Form (CRF) (OMB Control No. 0920-1385). The Revision will expand
the number of fungal diseases for which data may be collected.
In addition to triazole-resistant A. fumigatus infections,
coccidioidomycosis, histoplasmosis, blastomycosis, C. auris, and
antifungal-resistant dermatophytosis, CRFs have also been developed for
chromoblastomycosis, mycetoma, and sporotrichosis. We plan to use
standardized CRFs to collect public health surveillance data for cases
of these diseases regarding demographics (e.g., age, sex, race/
ethnicity, location of residence), underlying medical conditions,
diagnosis (e.g., clinical presentation, laboratory testing),
treatments, and outcomes (e.g., hospitalization, vital status). The
corresponding CRF would be filled out voluntarily by State, local or
Tribal health departments, Federal agencies, and the members of the
private sector (e.g., academic institutions) and contains a section for
medical chart review and an optional supplemental interview (including
data on potential occupational or environmental exposures) of the
patient or their representative.
Findings can help identify populations at higher risk of these
diseases, detect emerging epidemiologic trends, and guide prevention
and response efforts. They can also help better focus public and
healthcare provider outreach, inform efforts to contain or mitigate
spread, and influence health policy and research on prevention and
treatment.
CDC requests OMB approval for an estimated 1,564 annual burden
hours. There is no cost to respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number Avg. burden
Form name Type of respondent Number of responses per per response
respondents respondent (in hrs.)
----------------------------------------------------------------------------------------------------------------
Triazole-resistant Aspergillus State and Local Health 15 15 0.5
fumigatus Case Report Form Departments.
(Attachment 3a).
Coccidioidomycosis Case Report Form State and Local Health 10 25 1.0
(Attachment 3b). Departments.
Private Sectors......... 3 10 1.0
Histoplasmosis Case Report Form State and Local Health 10 25 1.0
(Attachment 3c). Departments.
Private Sectors......... 3 10 1.0
Blastomycosis Case Report Form State and Local Health 10 25 1.0
(Attachment 3d). Departments.
Private Sectors......... 3 10 1.0
Candida auris Case Report Form State and Local Health 15 20 0.75
(Attachment 3e). Departments.
Private Sectors......... 3 10 0.75
Antifungal-resistant dermatophytosis State and Local Health 10 10 0.5
case report form (Attachment 3f). Departments.
Chromoblastomycosis case report form Private Sectors......... 25 10 0.5
(Attachment 3g).
Mycetoma case report form (Attachment Private Sectors......... 25 5 0.5
3h).
Sporotrichosis case report form Private Sectors......... 25 10 0.5
(Attachment 3i).
----------------------------------------------------------------------------------------------------------------
[[Page 2706]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2025-00454 Filed 1-10-25; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on January 13, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.